ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
118.532,68
-1,33%
S&P 500
5.942,47
1,26%
US Dollar vs BRL
6,1822
0,00%
Bitcoin
98.557,06
0,46%
Brent Oil
76,495
0,00%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Onconetix Inc (ONCO)

  7. Onconetix Inc (ONCO) Notícias

ONCO

Onconetix (ONCO)

Onconetix Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ONCO
DataHoraFonteTítuloCódigoCompanhia
17/12/202408:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ONCOOnconetix Inc
13/12/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONCOOnconetix Inc
12/12/202419:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCOOnconetix Inc
12/12/202419:00GlobeNewswire Inc.Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent FilingNASDAQ:ONCOOnconetix Inc
11/12/202419:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ONCOOnconetix Inc
11/12/202408:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ONCOOnconetix Inc
15/11/202413:25Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ONCOOnconetix Inc
15/11/202412:45Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONCOOnconetix Inc
01/11/202418:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ONCOOnconetix Inc
01/11/202417:56Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ONCOOnconetix Inc
31/10/202417:20Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:ONCOOnconetix Inc
18/10/202417:10Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:ONCOOnconetix Inc
17/10/202412:53Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ONCOOnconetix Inc
09/10/202418:16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONCOOnconetix Inc
03/10/202417:45GlobeNewswire Inc.Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of CreditNASDAQ:ONCOOnconetix Inc
03/10/202410:05GlobeNewswire Inc.Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of CreditNASDAQ:ONCOOnconetix Inc
01/10/202417:35Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:ONCOOnconetix Inc
30/09/202420:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCOOnconetix Inc
27/09/202416:54Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ONCOOnconetix Inc
26/09/202417:08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ONCOOnconetix Inc
26/09/202407:16Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ONCOOnconetix Inc
20/09/202412:45GlobeNewswire Inc.Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of StockholdersNASDAQ:ONCOOnconetix Inc
03/09/202416:11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCOOnconetix Inc
29/08/202408:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCOOnconetix Inc
01/08/202417:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ONCOOnconetix Inc
22/07/202418:00Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:ONCOOnconetix Inc
15/07/202407:00GlobeNewswire Inc.Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross ProceedsNASDAQ:ONCOOnconetix Inc
11/07/202409:17GlobeNewswire Inc.Onconetix Announces Exercise of Warrants for $1.11 Million Gross ProceedsNASDAQ:ONCOOnconetix Inc
13/02/202408:00GlobeNewswire Inc.Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of DirectorsNASDAQ:ONCOOnconetix Inc
18/12/202309:00GlobeNewswire Inc.Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™NASDAQ:ONCOOnconetix Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ONCO

Seu Histórico Recente

BIT
DLG
De Longhi
BIT
P22462
NLBNPIT22462 20991231 41...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados